Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

Background: Multiple cardiovascular outcomes trials (CVOTs) have shown the efficacy of GLP-1RAs in reducing major adverse cardiovascular events (MACEs) for high-risk patients. However, some CVOTs failed to demonstrate cardiovascular benefits. Objectives: We analyzed the impact of GLP-1RA on cardiova...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Frederick Berro Rivera, Linnaeus Louisse A. Cruz, John Vincent Magalong, Jade Monica Marie J. Ruyeras, John Paul Aparece, Nathan Ross B. Bantayan, Kyla Lara-Breitinger, Martha Gulati
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-06-01
Serija:	American Journal of Preventive Cardiology
Teme:	Glucagon-like peptide 1 receptor agonists GLP-1RA Cardiovascular outcomes Renal outcomes MACE
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2666667724000473
Oznake:	Označite Brez oznak, prvi označite!